Nancy Lagat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Nancy Lagat has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Elijah Maritim Songok
Kenya Medical Research Institute, Nairobi, Kenya
2 shared publications - Fredrick Okoth
Centre for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya
2 shared publications - Raphael Wekesa Lihana
Centre for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya
2 shared publications - Ernest P Makokha
Centre for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya
1 shared publication - James Brooks
National HIV and Retrovirology Laboratories, National Microbiology Laboratory, Public Health Agency of Canada, Ottawa, Canada
1 shared publication - Joseph Muriuki
Centre for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya
1 shared publication
Latest Publications
- Open Access
- 4 November 2013
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 13 (1) , 517
HIV-1 drug resistance-associated mutations among HIV-1 infected drug-naïve antenatal clinic attendees in rural Kenya
Access to antiretroviral therapy (ART) has increased dramatically in Sub-Saharan Africa. In Kenya, 560,000 people had access to ART by the end of 2011. This scaling up of ART has raised challenges to the Kenyan health system due to emergence of drug resistant viruses among those on treatment and possible onward transmission. To counter this, and come up with an effective treatment strategy, it has become vital to determine baseline mutations associated with drug resistance among the circulating strains of HIV-1in Kenya.
- 4 November 2013
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 13 (1) , 517
Open AccessHIV-1 drug resistance-associated mutations among HIV-1 infected drug-naïve antenatal clinic attendees in rural Kenya
Access to antiretroviral therapy (ART) has increased dramatically in Sub-Saharan Africa. In Kenya, 560,000 people had access to ART by the end of 2011. This scaling up of ART has raised challenges to the Kenyan health system due to emergence of drug resistant viruses among those on treatment and possible onward transmission. To counter this, and come up with an effective treatment strategy, it has become vital to determine baseline mutations associated with drug resistance among the circulating strains of HIV-1in Kenya.
- Open Access
- 30 December 2009
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 9 (1) , 215
HIV-1 subtype and viral tropism determination for evaluating antiretroviral therapy options: an analysis of archived Kenyan blood samples
Infection with HIV-1 is characterized by genetic diversity such that specific viral subtypes are predominant in specific geographical areas. The genetic variation in HIV-1 pol and env genes is responsible for rapid development of resistance to current drugs. This variation has influenced disease progression among the infected and necessitated the search for alternative drugs with novel targets. Though successfully used in developed countries, these novel drugs are still limited in resource-poor countries. The aim of this study was to determine HIV-1 subtypes, recombination, dual infections and viral tropism of HIV-1 among Kenyan patients prior to widespread use of antiretroviral drugs.
- 30 December 2009
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 9 (1) , 215
Open AccessHIV-1 subtype and viral tropism determination for evaluating antiretroviral therapy options: an analysis of archived Kenyan blood samples
Infection with HIV-1 is characterized by genetic diversity such that specific viral subtypes are predominant in specific geographical areas. The genetic variation in HIV-1 pol and env genes is responsible for rapid development of resistance to current drugs. This variation has influenced disease progression among the infected and necessitated the search for alternative drugs with novel targets. Though successfully used in developed countries, these novel drugs are still limited in resource-poor countries. The aim of this study was to determine HIV-1 subtypes, recombination, dual infections and viral tropism of HIV-1 among Kenyan patients prior to widespread use of antiretroviral drugs.